footer-social-menu

Sign Up for Emails

CONNECT WITH GALE

Stay up-to-date with the latest Gale news, exclusive offers, and more.

facebook

linkedin

instagram

youtube

SOCIAL ICONS

secondary-account-menu

Profile

Orders

Wish List

Fast Order Entry

My Account

single-column

secondary-storefront-menu

International

North America

China

Japan

Latin America

Brazil

Region

Set your region:

config

%1 products have been added to your cart but %2 have been backordered and will be fulfilled when stock is available

Product on backorder

Current quantity limit is [maxProductQuantity], please, navigate to the cart page and change quantity of product

You will be able to resubmit promo in ${countdown} seconds. test

Please note that the taxes displayed on our website are estimated and subject to adjustment. The actual tax charges will be determined and settled during the final invoicing of your order

product-detail-component

products

Marketing materials, training documents, discovery services

cengage:card

FIND YOUR SALES REPRESENTATIVE

cengage:column

Get marketing materials, training documents, discovery services.

PRODUCT SUPPORT

CUSTOMER SUPPORT

Report technical issues, errors, check system status

TECHNICAL SUPPORT

Manage product preferences, generate usage reports, simplify administrative tasks.

ADMIN TOOLS

support

container

footer-legal-menu

Terms of use

Privacy

zone1

cengage:galethorndikeseo

footer-menu

Academic Institutions

K-12

Public Libraries

Government and Special Libraries

Statewide Programs

Institutions

Databases

Primary Sources

Digital Humanities Tools

eLearning

Schools/K-12 Curriculum

Books

Large Print Books by Thorndike Press

Products

Find Your Rep

Product Support

Technical Support

Customer Support

Admin Tools

Accessibility Policy

Support

About Us

Blogs

Press Center

Events

News

Careers

Partnerships

Contact Us

Our Company

zone3

mega-menu

footer

secondary-primary-menu

Request a Trial

footer-social-menu-component

zone2

footer-legal-menu-component

footer-menu-component

gale-footer

FIND YOUR REP

support-order-2

header-component

Would you like to go to the Gale {{RECOMMENDED_COUNTRY}} site instead?

It looks like you're visiting from {{DETECTED_COUNTRY}}.

main

Browse by Institution Type

Browse by Product Type

You may already have access to Gale content through your institution.

STUDENTS AND RESEARCHERS

support-order-1

header

Account Information

bundle-connector

Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics

NONCLINICAL DEV NVL BIOLGCS BIOSMLRS VCCNS SPCLTY BLGCS

Life Science

Mathematics & Science

Genetics

Gt Product Group

Binding Format

Marketing Imprint Name

B2B GT

CL Carton Count

Imprint Name

B2B & B2C

Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics is a complete reference devoted to the nonclinical safety assessment of novel biopharmaceuticals, biosimilars, vaccines, cell and gene therapies and blood products. This book compares and contrasts these types of biologics with one another and with small molecule drugs, while incorporating the most current and essential international regulatory documents. Each section discusses a different type of biologic, as well as early characterization strategies, principles of study design, preclinical pharmacokinetics and pharmacodynamics and preclinical assays. An edited book that is authored by leading experts in the field, this comprehensive reference provides critical insights to all researchers involved in early through late stage biologics.

POST SECONDARY FOUR YEAR

COLFR

COLSO

COLJR

COLSR

Duration

Duration Unit Of Measure

Transaction Type

Front Cover.
Half Title Page.
Title Page.
Copyright Page.
Dedication.
Table of Contents.
Preface.
Contributors.
Acknowledgments.
1: Development of Biopharmaceuticals Defined as Novel Biologics.
2: Overview of Biopharmaceuticals and Comparison with Small-molecule Drug Development.
3: Regulatory Guidelines and their Application in the Nonclinical Evaluation of Biological Medicines.
4: Early De-risking Strategy for Novel Biotherapeutics.
5: Novel Biopharmaceuticals: Pharmacokinetics, Pharmacodynamics, and Bioanalytics.
6: Development of Biosimilars.
7: Overview of Biosimilar Therapeutics.
8: Regulatory Standards for the Approval of Biosimilar Products: A Global Review.
9: Early Characterization of Biosimilar Therapeutics.
10: Vaccines.
11: Introduction to Vaccines and Adjuvants.
12: Global Regulatory Guidelines for Vaccines.
13: Special Considerations for the Nonclinical Safety Assessment of Vaccines.
14: Specialty Biologics and Indications.
15: Turning the Corner with Viral-based Gene Therapy&#x2014;Development of the Rogue Biopharmaceutical.
16: Blood Products.
17: Biological Therapies for Cancer.
18: Nonclinical Development of Multi-targeting Biopharmaceuticals.
19: Considerations in the Development of Pluripotent Stem Cell-based Therapies.
Color Plates.
Index.

Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics.css-1p8rvzy{position:absolute;padding-left:8px;}

Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics